Ignite Creation Date:
2024-05-06 @ 3:54 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04799405
Status:
COMPLETED
Last Update Posted:
2022-03-24
First Post:
2021-03-10
Brief Title:
Home-based tDCS in Major Depressive Disorder
Sponsor:
Hebrew SeniorLife
Organization:
Hebrew SeniorLife
Study Overview
Official Title:
Supervised Home-based Transcranial Direct Current Stimulation tDCS for Major Depressive Disorder
Status:
COMPLETED
Status Verified Date:
2022-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MoodStim
Brief Summary:
The investigators propose a study of telehealth supervised caregiver-delivered home-based transcranial direct current stimulation tDCS for antidepressant treatment of patients with an acute depressive episode
Detailed Description:
This is an open-label pilot feasibility telemedicine study This pilot will involve a total of 37 stimulations sessions at home visits 30- minute sessions of multichannel excitatory tDCS targeting the left DPFC and the maintenance of a daily treatment diary to be completed by the subjects immediately after enrollment and 12 weeks following the last study visit
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None